Skin microbiota alterations induce dysregulated IL-1 alpha responses that drive atopic dermatitis-like skin inflammation
N. Archer,S. Lee,J. Jo,D. Kim,R. Ortines,Y. Wang,M. Marchitto,A. Ravipati,S. Cai,C. Dillen,H. Liu,R. Miller,A. Ashbaugh,A. Uppal,M. Oyoshi,N. Malhotra,S. Hoff,L. Garza,H. Kong,J. Segre,R. Geha,L. S. Miller
DOI: https://doi.org/10.1016/j.jid.2018.03.961
IF: 7.59
2018-01-01
Journal of Investigative Dermatology
Abstract:Skin microbiome alterations are associated with initiation and flares of atopic dermatitis (AD) but how they contribute to skin inflammation are incompletely understood. Skin injury of filaggrin-deficient (ft/ft) mice with a defective skin barrier induced chronic AD-like inflammation that was reversed after treatment with neutralizing antibodies IL-1α but not IL-1β. Moreover, treatment of the inflamed skin with either topical antibiotics (Neosporin) or co-housing with wildtype mice, which reduces or intermixes the skin microflora, resolved the inflammation, indicating a pathogenic role for both IL-1α and the skin microbiome. Based upon 16S rDNA sequencing of skin swabs, the microbial diversity was stable in ft/ft mice prior to and following injury-induced skin inflammation. However, after co-housing ft/ft mice with wildtype mice, there was a significant shift in the skin microbial diversity, which corresponded with the resolution of skin inflammation and IL-1α dysregulation. Deeper taxonomic analysis revealed that the co-housing of ft/ft mice altered the abundance of specific bacterial species that likely contributed to the resultant skin inflammation. Taken together, skin microbial alternations were sufficient to induce aberrant IL-1α responses that mediated chronic skin inflammation, providing novel targets for therapeutic intervention in AD.